And despite myself being born in India, I am appalled that our legal system allows these foreign generics to steal the incredible risk & effort that a small company like AMRN took over several years to complete the reduce-it trial involving thousands of patients. The lack of advertising from AMRN will cost thousands of lives here in U.S.
I truly wish Peter Navarro/Trump would hear of this travesty wreaked by this judge. Either Du is a dimwit or else corrupt. Nothing else can explain.
I go with "something more sinister", I always think AMRN has to be at a US BP's hands for national interests, a buyout price $20B, guess AMNR may be really asking $30+B, and today's decision is the way FDA+BP pay back to AMRN not playing with the US unspoken rules, IMO.
Market Data 
Markets 
AI
